Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Shenzhen Ampron Technology
301413
Profit Cultural & Creative Group
300640
CN Stock MarketDetailed Quotes
000756 Shandong Xinhua Pharmaceutical
- 15.79
- -0.84-5.05%
Trading Jan 10 11:10 CST
10.78BMarket Cap24.03P/E (TTM)
16.59High15.61Low279.60KlotVolume16.40Open16.63Pre Close445.64MTurnover6.23%Turnover Ratio21.69P/E (Static)682.41MShares20.6152wk High2.21P/B7.09BFloat Cap13.1852wk Low18.29Limit Up448.77MShs Float48.38Historical High14.97Limit Down5.89%Amplitude0.54Historical Low0.28Dividend TTM15.94Avg Price166.96KlotAsk1.74%Div YieldTTM100Lot Size102.29KlotBid
Shandong Xinhua Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.64%6.73B | 1.29%4.73B | -6.25%2.47B | 7.97%8.1B | 19.15%6.5B | 27.51%4.67B | 44.15%2.64B | 14.37%7.5B | 10.39%5.45B | 3.19%3.66B |
| Operating revenue | 3.64%6.73B | 1.29%4.73B | -6.25%2.47B | 7.97%8.1B | 19.15%6.5B | 27.51%4.67B | 44.15%2.64B | 14.37%7.5B | 10.39%5.45B | 3.19%3.66B |
| Other operating revenue | ---- | -1.58%75.88M | ---- | -30.33%144.78M | ---- | -36.97%77.11M | ---- | 3.63%207.82M | ---- | 133.33%122.33M |
| Total operating cost | 4.93%6.34B | 2.38%4.41B | -5.33%2.33B | 7.27%7.53B | 18.00%6.04B | 25.93%4.31B | 44.40%2.46B | 13.72%7.02B | 11.39%5.12B | 4.81%3.42B |
| Operating cost | 11.82%5.15B | 8.13%3.55B | -0.86%1.8B | 4.45%5.71B | 14.21%4.61B | 21.00%3.28B | 36.14%1.81B | 14.19%5.47B | 13.49%4.03B | 7.98%2.71B |
| Operating tax surcharges | -34.27%51.66M | -38.98%36.9M | -56.17%18.43M | 41.14%92.18M | 61.26%78.6M | 91.30%60.48M | 156.99%42.06M | 10.20%65.31M | 9.44%48.74M | 0.07%31.61M |
| Operating expense | -21.64%504.22M | -17.14%403.57M | -17.52%291.06M | 18.51%780.17M | 42.03%643.45M | 65.35%487.04M | 114.72%352.9M | 12.70%658.31M | -0.28%453.05M | -17.81%294.56M |
| Administration expense | -18.59%292.41M | -26.49%181.07M | -37.52%78.84M | 13.30%513.82M | 16.68%359.16M | 21.27%246.32M | 24.33%126.17M | 29.70%453.53M | 20.73%307.8M | 20.16%203.11M |
| Financial expense | 9.12%10.21M | 20.56%1.62M | -81.02%2.95M | -48.93%16.35M | -40.86%9.36M | -90.75%1.34M | 26.88%15.57M | -39.47%32.02M | -59.36%15.83M | -45.41%14.5M |
| -Interest expense (Financial expense) | -11.33%28.12M | -16.85%17.87M | -21.92%9.22M | -17.22%41.15M | -14.42%31.71M | -11.85%21.49M | -5.82%11.8M | -6.40%49.71M | -8.49%37.05M | -10.12%24.38M |
| -Interest Income (Financial expense) | 14.27%-8.32M | 31.95%-4.58M | 22.18%-2.88M | -17.57%-12.3M | -50.52%-9.71M | -84.60%-6.73M | -161.86%-3.7M | -19.21%-10.46M | -5.46%-6.45M | 12.08%-3.65M |
| Research and development | -4.28%326.67M | 3.22%243.11M | 26.57%141.91M | 21.29%419.24M | 32.03%341.28M | 39.72%235.53M | 42.36%112.12M | 1.26%345.66M | 4.49%258.5M | -0.99%168.57M |
| Credit Impairment Loss | -161.42%-8.07M | -135.60%-8.19M | 13,900.00%70K | -102.82%-10.29M | -51.93%-3.09M | -71.09%-3.48M | --500 | -289.12%-5.08M | 57.27%-2.03M | 57.27%-2.03M |
| Asset Impairment Loss | -8.96%-48.31M | -8.96%-48.31M | ---- | -59.17%-69.28M | -51.08%-44.34M | -51.08%-44.34M | ---- | -30.84%-43.53M | 15.21%-29.35M | 16.02%-29.35M |
| Other net revenue | 110.46%1.19M | 59.65%-10.72M | 295.08%24.79M | -509.37%-35.36M | -510.35%-11.41M | -903.12%-26.56M | 1.35%6.27M | -114.78%-5.8M | 330.56%2.78M | 87.36%-2.65M |
| Invest income | -13.31%8.4M | 14.85%9.52M | 1,423.42%1.19M | 14.57%9.58M | -5.91%9.69M | -21.29%8.29M | -46.90%78.03K | 4.34%8.36M | 75.49%10.3M | 48.34%10.53M |
| -Including: Investment income associates | -85.73%217.37K | 1,006.56%1.33M | 1,423.42%1.19M | 217.01%1.42M | -35.98%1.52M | -95.38%120.59K | -46.90%78.03K | 141.08%447.18K | 173.49%2.38M | 337.48%2.61M |
| Asset deal income | -85.49%1.2M | -2.66%1.24M | 60.97%845.11K | 57.66%8.73M | 308.47%8.28M | -48.08%1.27M | 14.64%525.02K | 167.25%5.54M | 241.48%2.03M | 3,521.59%2.45M |
| Other revenue | 165.77%47.98M | 199.54%35.03M | 300.03%22.68M | -10.36%25.9M | -17.33%18.05M | -25.76%11.7M | 1.52%5.67M | -51.63%28.89M | -31.12%21.84M | 35.94%15.75M |
| Operating profit | -10.88%398.27M | -7.90%307.57M | -8.20%170.56M | 12.14%534.58M | 32.18%446.87M | 40.46%333.96M | 38.96%185.8M | 12.01%476.71M | -1.78%338.08M | -9.66%237.76M |
| Add:Non operating Income | -84.28%659.43K | -48.33%326.56K | -46.13%193.82K | 195.38%5.54M | 215.97%4.19M | -8.06%632.02K | 71.64%359.78K | -50.96%1.87M | 24.63%1.33M | -10.00%687.43K |
| Less:Non operating expense | 31.07%6.01M | 71.53%4.53M | 59.81%1.98M | 9.21%7.43M | -4.44%4.59M | -15.72%2.64M | -37.33%1.24M | -16.79%6.81M | -8.75%4.8M | -12.76%3.14M |
| Total profit | -12.00%392.92M | -8.61%303.36M | -8.73%168.77M | 12.91%532.69M | 33.43%446.48M | 41.06%331.95M | 40.15%184.92M | 12.00%471.77M | -1.59%334.61M | -9.62%235.32M |
| Less:Income tax cost | -18.88%37.47M | -45.62%30.6M | -23.95%23.51M | -41.80%26.58M | 47.04%46.19M | 52.84%56.27M | 37.22%30.91M | -22.81%45.66M | -26.54%31.41M | -27.88%36.81M |
| Net profit | -11.20%355.45M | -1.06%272.77M | -5.68%145.26M | 18.77%506.11M | 32.02%400.29M | 38.88%275.68M | 40.75%154.01M | 17.69%426.11M | 2.00%303.2M | -5.17%198.5M |
| Net profit from continuing operation | -11.20%355.45M | -1.06%272.77M | -5.68%145.26M | 18.77%506.11M | 32.02%400.29M | 38.88%275.68M | 40.75%154.01M | 17.69%426.11M | 2.00%303.2M | -5.17%198.5M |
| Less:Minority Profit | 36.63%11.37M | 25.35%7.36M | 40.64%3.38M | -36.23%9.59M | -14.68%8.32M | 42.75%5.87M | 163.02%2.41M | 11.24%15.05M | -18.15%9.75M | -55.45%4.11M |
| Net profit of parent company owners | -12.22%344.08M | -1.63%265.4M | -6.41%141.88M | 20.79%496.51M | 33.58%391.97M | 38.80%269.81M | 39.72%151.6M | 17.94%411.06M | 2.84%293.44M | -2.85%194.39M |
| Earning per share | ||||||||||
| Basic earning per share | -13.79%0.5 | -2.50%0.39 | -8.70%0.21 | 19.35%0.74 | 28.89%0.58 | 33.33%0.4 | 35.29%0.23 | 10.71%0.62 | -2.17%0.45 | -6.25%0.3 |
| Diluted earning per share | -12.28%0.5 | -2.56%0.38 | -4.55%0.21 | 18.03%0.72 | 29.55%0.57 | 30.00%0.39 | 29.41%0.22 | 8.93%0.61 | -2.22%0.44 | -6.25%0.3 |
| Other composite income | 208.26%74.96M | 96.98%27.33M | -89.42%815.33K | 113.41%1.74M | 209.72%24.32M | 243.00%13.87M | 152.81%7.71M | 73.13%-12.94M | 53.84%-22.16M | 74.22%-9.7M |
| Other composite income of parent company owners | 215.13%75.22M | 106.79%27.6M | -89.77%807.37K | 110.56%1.49M | 201.01%23.87M | 228.81%13.35M | 154.25%7.89M | 70.52%-14.13M | 50.72%-23.63M | 72.38%-10.36M |
| Other composite income of minority owners | -158.71%-262.39K | -152.07%-273.92K | 104.40%7.95K | -79.36%244.75K | -69.55%446.91K | -20.32%526.05K | -240.36%-180.97K | 577.34%1.19M | 2,326.25%1.47M | 709.34%660.24K |
| Total composite income | 1.37%430.41M | 3.64%300.09M | -9.67%146.08M | 22.91%507.84M | 51.09%424.61M | 53.36%289.55M | 70.55%161.72M | 31.62%413.17M | 12.76%281.03M | 9.97%188.8M |
| Total composite income of parent company owners | 0.83%419.3M | 3.48%293.01M | -10.54%142.69M | 25.46%498M | 54.12%415.84M | 53.86%283.15M | 69.75%159.49M | 32.03%396.94M | 13.66%269.81M | 13.20%184.03M |
| Total composite income of minority owners | 26.67%11.11M | 10.76%7.09M | 52.43%3.39M | -39.38%9.84M | -21.85%8.77M | 34.03%6.4M | 158.25%2.23M | 22.26%16.23M | -5.31%11.22M | -47.68%4.77M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
